Breaking News

Thursday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Recommendations	Conmed price target lowered to $110 from $160 at Stifel » 06:47 06/23/22 06/23 06:47 06/23/22 06:47 CNMD Conmed $89.59 / +0.16 (+0.18%) Stifel analyst Rick Wise… Stifel analyst Rick Wise lowered the firm's price target on Conmed to $110 from $160 and keeps a Buy rating on the shares. Recent conversations with foot-and-ankle orthopedic surgeons/podiatrists to better understand Conmed's just-closed In2Bones acquisition left Wise encouraged that In2Bones does represent a meaningful addition to Conmed's Orthopedic Surgery division, opening up the faster-growing extremities market, the analyst tells investors in a research note. The analyst believes the In2Bones transaction will prove to be a compelling, highly-complementary addition to Conmed's portfolio for years to come. ShowHide Related Items >><< Company News Street Research Earnings On The Fly CNMD Conmed $89.59 / +0.16 (+0.18%) 06/13/22 Conmed completes acquisition of In2Bones Global 05/04/22 Conmed to acquire In2Bones Global for $145M CNMD Conmed $89.59 / +0.16 (+0.18%) 04/19/22 Piper Sandler Piper Sandler continues to recommend exposure to medtech space after J&J results 03/02/22 BofA Conmed reinstated with a Neutral at BofA 10/27/21 Piper Sandler Conmed should be bought on any weakness, says Piper Sandler 10/06/21 Fly Intel: Top five analyst upgrades CNMD Conmed $89.59 / +0.16 (+0.18%) 05/04/22 Conmed cuts FY22 adjusted EPS view to $3.50-$3.65, consensus $3.69 05/04/22 Conmed reports Q1 adjusted EPS 70c, consensus 62c 01/26/22 Conmed sees FY22 adjusted EPS $3.60-$3.85, consensus $3.74 01/26/22 Conmed reports Q4 adjusted EPS $1.07, consensus $1.06 CNMD Conmed $89.59 / +0.16 (+0.18%) 05/31/22 Fly Intel: After-Hours Movers

Over a week ago
Hot Stocks	Conmed completes acquisition of In2Bones Global » 16:08 06/13/22 06/13 16:08 06/13/22 16:08 CNMD Conmed $96.02 / -6.94 (-6.74%) CONMED "announced… CONMED "announced that it has completed its previously announced acquisition of privately-held In2Bones Global Inc. The transaction is being financed through a combination of the net proceeds of the Company's 2.25% convertible notes, which were issued on June 6, 2022, borrowings under the Company's amended and restated credit facility, and cash on hand. The Company will provide additional guidance regarding the impact of the transaction on 2022 financial results when it reports second quarter financial results in late July." ShowHide Related Items >><< Company News Street Research Earnings On The Fly CNMD Conmed $96.02 / -6.94 (-6.74%) 05/04/22 Conmed to acquire In2Bones Global for $145M CNMD Conmed $96.02 / -6.94 (-6.74%) 04/19/22 Piper Sandler Piper Sandler continues to recommend exposure to medtech space after J&J results 03/02/22 BofA Conmed reinstated with a Neutral at BofA 10/27/21 Piper Sandler Conmed should be bought on any weakness, says Piper Sandler 10/06/21 Fly Intel: Top five analyst upgrades CNMD Conmed $96.02 / -6.94 (-6.74%) 05/04/22 Conmed cuts FY22 adjusted EPS view to $3.50-$3.65, consensus $3.69 05/04/22 Conmed reports Q1 adjusted EPS 70c, consensus 62c 01/26/22 Conmed sees FY22 adjusted EPS $3.60-$3.85, consensus $3.74 01/26/22 Conmed reports Q4 adjusted EPS $1.07, consensus $1.06 CNMD Conmed $96.02 / -6.94 (-6.74%) 05/31/22 Fly Intel: After-Hours Movers
On The Fly	Fly Intel: After-Hours Movers » 17:40 05/31/22 05/31 17:40 05/31/22 17:40 CRM Salesforce $160.60 / -4.5 (-2.73%) , VSCO Victoria's Secret $41.27 / -1.37 (-3.21%) , VTOL Bristow Group $31.73 / +0.04 (+0.13%) , SIX Six Flags $29.36 / -0.64 (-2.13%) , HPQ HP Inc. $38.79 / +0.06 (+0.15%) , LPI Laredo Petroleum $84.19 / -0.75 (-0.88%) , OSTK Overstock.com $31.02 / -1.295 (-4.01%) , AMBA Ambarella $85.23 / -2.895 (-3.29%) , SPWH Sportsman's Warehouse $9.45 / -0.11 (-1.15%) , APPS Digital Turbine $25.45 / -1.16 (-4.36%) , CHPT ChargePoint $12.75 / -0.71 (-5.27%) , CNCE Concert Pharmaceuticals $6.36 / +0.5 (+8.53%) , CNMD Conmed $116.37 / +0.315 (+0.27%) Check out this evening's… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options VTOL VSCO SPWH SIX OSTK LPI HPQ CRM CNMD CNCE CHPT APPS AMBA VTOL Bristow Group $31.73 / +0.04 (+0.13%) 04/29/22 Bristow Group to acquire British International Helicopter Services, no terms 02/04/22 Bristow Group falls -11.7% 01/19/22 Bristow Group to provide helicopter services to Netherlands coastguard 12/16/21 Bristow, Overair form strategic partnership to introduce Butterfly VSCO Victoria's Secret $41.27 / -1.37 (-3.21%) 05/26/22 Victoria's Secret launches VS&Co-Lab digital platform 05/16/22 David Einhorn's Greenlight adds Southwestern, exits Sonos in Q1 04/29/22 Victoria's Secret & PINK Beauty launch in Amazon's store 04/06/22 Victoria's Secret completes JV agreement with Regina Miracle for China SPWH Sportsman's Warehouse $9.45 / -0.11 (-1.15%) 05/27/22 Sportsman's Warehouse appoints Sherry Jane Love as SVP, merchandising 05/16/22 Sportsman's Warehouse appoints Sruti Patnaik as chief information officer 03/24/22 Sportsman's Warehouse board approves $75M share repurchase program 02/01/22 Sportsman's Warehouse appoints Jeff White CFO SIX Six Flags $29.36 / -0.64 (-2.13%) 05/31/22 Six Flags names Gary Mick as new CFO 05/17/22 Six Flags director buys $12.26M in common stock 05/12/22 Six Flags trading resumes 05/12/22 Six Flags trading halted, volatility trading pause OSTK Overstock.com $31.02 / -1.295 (-4.01%) 05/31/22 Overstock.com up 2.5% at $31.77 after Simcoe disclosed 5.7% stake 05/31/22 Simcoe Capital discloses 5.7% activist stake in Overstock.com 04/28/22 Overstock.com reports Q1 active customers 7.4M, down 26% y/y 02/23/22 Overstock.com reports Q4 active customers 8.1M, down 12% y/y LPI Laredo Petroleum $84.19 / -0.75 (-0.88%) 05/31/22 Laredo Petroleum announces $200M share repurchase program 01/06/22 Laredo Petroleum rises 6.7% 12/29/21 Laredo Petroleum falls -6.9% HPQ HP Inc. $38.79 / +0.06 (+0.15%) 05/27/22 Poly not providing FY23 guidance 05/23/22 HP Inc. names Ernest Nicolas as chief supply chain officer 05/19/22 HP Inc. debuts new HP Spectre, HP Envy laptops 05/18/22 HP Inc. reveals new gaming hardware, software CRM Salesforce $160.60 / -4.5 (-2.73%) 05/31/22 Salesforce reports Q1 cRPO up 21% y/y at $21.5B 05/10/22 Salesforce to acquire Troops.ai, terms not disclosed 03/25/22 Salesforce changes legal name to Salesforce, Inc. 03/23/22 Theta Lake attracts $50M in series B funding CNMD Conmed $116.37 / +0.315 (+0.27%) 05/04/22 Conmed to acquire In2Bones Global for $145M CNCE Concert Pharmaceuticals $6.36 / +0.5 (+8.53%) 05/23/22 Concert :THRIVE-AA1 study meets primary endpoint for scalp hair regrowth 01/04/22 Concert Pharmaceuticals completes enrollment in THRIVE-AA2 trial CHPT ChargePoint $12.75 / -0.71 (-5.27%) 04/13/22 ChargePoint :1st of six Colorado electric vehicle fast-charging corridors done 03/29/22 ChargePoint, Goldman Sachs partner to introduce new financing solutions 03/28/22 ChargePoint, Gatik enter electric ecosystem partnership 03/22/22 Toyota North America partners with ChargePoint on public EV charging solutions APPS Digital Turbine $25.45 / -1.16 (-4.36%) 05/31/22 Digital Turbine delays 10-K filing 05/17/22 Digital Turbine says FY22 quarterly results to be restated 04/27/22 Digital Turbine enters multiyear partnership with AccuWeather 02/16/22 Google announces 'Privacy Sandbox on Android' AMBA Ambarella $85.23 / -2.895 (-3.29%) 04/05/22 Lumentum, Ambarella announce a new joint reference design Vision-D 03/28/22 Ambarella hires new CFO, Brian White, formerly with Maxim Integrated Products 03/21/22 Ambarella announces passing of CFO Casey Eichler 03/16/22 Ambarella, Helm.ai announce ADAS software integration CRM VSCO VTOL SIX HPQ LPI OSTK AMBA SPWH APPS CHPT CNCE CNMD CRM Salesforce $160.60 / -4.5 (-2.73%) 05/24/22 BofA Salesforce, CNH removed from US 1 list at at BofA 05/24/22 Oppenheimer Salesforce price target lowered to $205 from $310 at Oppenheimer 05/23/22 Jefferies Salesforce price target lowered to $260 from $330 at Jefferies 05/23/22 Cowen Salesforce price target lowered to $225 from $285 at Cowen VSCO Victoria's Secret $41.27 / -1.37 (-3.21%) 05/16/22 JPMorgan Victoria's Secret price target lowered to $71 from $86 at JPMorgan 04/05/22 Wells Fargo Victoria's Secret price target lowered to $70 from $75 at Wells Fargo 04/01/22 Barclays Victoria's Secret price target lowered to $61 from $76 at Barclays 03/03/22 BMO Capital Victoria's Secret price target lowered to $72 from $80 at BMO Capital VTOL Bristow Group $31.73 / +0.04 (+0.13%) SIX Six Flags $29.36 / -0.64 (-2.13%) 05/13/22 Truist Six Flags price target lowered to $32 from $46 at Truist 05/13/22 Jefferies Six Flags remains a 'top pick' after Q1 results, says Jefferies 05/13/22 Stifel Six Flags' post-earnings reaction 'perplexing,' says Stifel 05/13/22 Deutsche Bank Six Flags price target lowered to $56 from $57 at Deutsche Bank HPQ HP Inc. $38.79 / +0.06 (+0.15%) 05/25/22 JPMorgan HP Inc. price target lowered to $39 from $41 at JPMorgan 05/23/22 Citi HP Inc. downgraded to Neutral from Buy at Citi 05/18/22 Jefferies Information Technology sector upgraded to Bullish at Jefferies 05/16/22 Evercore ISI HP Inc. added to 'Tactical Outperform' list at Evercore ISI LPI Laredo Petroleum $84.19 / -0.75 (-0.88%) 05/24/22 Raymond James Laredo Petroleum price target lowered to $85 from $120 at Raymond James 04/07/22 Piper Sandler Laredo Petroleum upgraded to Overweight from Neutral at Piper Sandler 03/23/22 Raymond James Laredo Petroleum price target raised to $100 from $85 at Raymond James 03/10/22 Piper Sandler Laredo Petroleum price target raised to $93 from $79 at Piper Sandler OSTK Overstock.com $31.02 / -1.295 (-4.01%) 05/17/22 Wedbush Overstock.com removed from Best Ideas List at Wedbush 04/28/22 Wedbush Overstock.com price target lowered to $66 from $95 at Wedbush 04/25/22 BofA BofA cuts Overstock.com to Neutral, sees revenue down 9% 04/25/22 BofA Overstock.com downgraded to Neutral from Buy at BofA AMBA Ambarella $85.23 / -2.895 (-3.29%) 05/27/22 Jefferies Ambarella price target lowered to $136 from $160 at Jefferies 05/26/22 Wells Fargo Ambarella price target lowered to $125 from $175 at Wells Fargo 04/20/22 Deutsche Bank Ambarella price target lowered to $115 from $140 at Deutsche Bank 03/18/22 Jefferies 2022 could be inflection year for Ambarella advanced ADAS wins, says Jefferies SPWH Sportsman's Warehouse $9.45 / -0.11 (-1.15%) 05/17/22 B. Riley Sportsman's Warehouse initiated with a Buy at B. Riley 03/30/22 Piper Sandler Sportsman's Warehouse price target raised to $12 from $11 at Piper Sandler 12/28/21 Lake Street Lake Street names 18 small cap best ideas for 2022 12/06/21 Lake Street Sportsman's Warehouse upgraded to Buy from Hold at Lake Street APPS Digital Turbine $25.45 / -1.16 (-4.36%) 02/16/22 Roth Capital Roth says Google news creates more unwarranted noise around Digital Turbine 02/16/22 Oppenheimer Google changes to make Digital Turbine access 'more valuable,' says Oppenheimer 02/09/22 Maxim Digital Turbine price target lowered to $108 from $132 at Maxim 02/09/22 Macquarie Digital Turbine price target lowered to $70 from $80 at Macquarie CHPT ChargePoint $12.75 / -0.71 (-5.27%) 05/26/22 JPMorgan ChargePoint price target lowered to $18 from $22 at JPMorgan 04/21/22 Tudor Pickering ChargePoint initiated with a Buy at Tudor Pickering 03/29/22 Stifel Partnership with GS Renewable Power positive for ChargePoint, says Stifel 03/15/22 BofA ChargePoint topline growth 'set to soar' as cash burn accelerates, says BofA CNCE Concert Pharmaceuticals $6.36 / +0.5 (+8.53%) 05/23/22 H.C. Wainwright Concert has potential best-in-class alopecia areata drug, says H.C. Wainwright 05/23/22 Mizuho Concert Phase 3 data in alopecia areata 'impressive,' says Mizuho 11/12/21 JMP Securities Concert Pharmaceuticals price target lowered to $10 from $17 at JMP Securities 10/05/21 Mizuho Concert Pharmaceuticals price target lowered to $9 from $13 at Mizuho CNMD Conmed $116.37 / +0.315 (+0.27%) 04/19/22 Piper Sandler Piper Sandler continues to recommend exposure to medtech space after J&J results 03/02/22 BofA Conmed reinstated with a Neutral at BofA 10/27/21 Piper Sandler Conmed should be bought on any weakness, says Piper Sandler 10/06/21 Fly Intel: Top five analyst upgrades VTOL VSCO SPWH SIX OSTK LPI HPQ CRM CNMD CNCE CHPT APPS AMBA VTOL Bristow Group $31.73 / +0.04 (+0.13%) 05/31/22 Bristow Group reports Q4 EPS (15c) vs. 0c last year 02/03/22 Bristow Group reports Q3 EPS 0c, one estimate 41c VSCO Victoria's Secret $41.27 / -1.37 (-3.21%) 05/31/22 Victoria's Secret sees Q2 EPS 95c-$1.25 , consensus $1.19 05/31/22 Victoria's Secret reports Q1 EPS $1.11, consensus 84c 05/31/22 Notable companies reporting after market close 03/02/22 Victoria's Secret sees FY22 revenue flat to up low-single digits SPWH Sportsman's Warehouse $9.45 / -0.11 (-1.15%) 05/31/22 Sportsman's Warehouse sees Q2 EPS 22c-30c, consensus 32c 05/31/22 Sportsman's Warehouse reports Q1 EPS 5c, consensus 0c 03/29/22 Sportsman's Warehouse sees Q1 adjusted EPS (1c)-1c, consensus (1c) 03/29/22 Sportsman's Warehouse reports Q4 adjusted EPS 49c, consensus 46c SIX Six Flags $29.36 / -0.64 (-2.13%) 05/12/22 Six Flags reports Q1 EPS (76c), consensus ($1.04) 05/11/22 Notable companies reporting before tomorrow's open 02/24/22 Six Flags reports Q4 EPS (2c), consensus (8c) OSTK Overstock.com $31.02 / -1.295 (-4.01%) 04/28/22 Overstock.com reports Q1 EPS 21c, consensus 22c 02/23/22 Overstock.com reports Q4 diluted cont ops EPS 68c, consensus 32c LPI Laredo Petroleum $84.19 / -0.75 (-0.88%) 05/04/22 Laredo Petroleum reports Q1 adjusted EPS $5.17, consensus $6.11 02/22/22 Laredo Petroleum reports Q4 EPS $3.39, consensus $3.34 HPQ HP Inc. $38.79 / +0.06 (+0.15%) 05/31/22 HP Inc. raises FY22 EPS view to $4.24-$4.38 from $4.18-$4.38, consensus $4.25 05/31/22 HP Inc. sees Q3 EPS $1.03-$1.08, consensus $1.02 05/31/22 HP Inc. reports Q2 EPS $1.08, consensus $1.05 CRM Salesforce $160.60 / -4.5 (-2.73%) 05/31/22 Salesforce jumps 5.5% to $169.12 after Q1 earnings beat 05/31/22 Salesforce cuts FY23 revenue view to $31.7B-$31.8B, consensus $32.06B 05/31/22 Salesforce sees Q2 revenue $7.69B-$7.70B, consensus $7.77B 05/31/22 Salesforce sees FY23 EPS $4.74-$4.76, consensus $4.65 CNMD Conmed $116.37 / +0.315 (+0.27%) 05/04/22 Conmed cuts FY22 adjusted EPS view to $3.50-$3.65, consensus $3.69 05/04/22 Conmed reports Q1 adjusted EPS 70c, consensus 62c 01/26/22 Conmed sees FY22 adjusted EPS $3.60-$3.85, consensus $3.74 01/26/22 Conmed reports Q4 adjusted EPS $1.07, consensus $1.06 CNCE Concert Pharmaceuticals $6.36 / +0.5 (+8.53%) 05/05/22 Concert Pharmaceuticals reports Q1 EPS ($1.03), consensus (91c) 03/03/22 Concert Pharmaceuticals reports Q4 EPS ($1.01), consensus (73c) CHPT ChargePoint $12.75 / -0.71 (-5.27%) 05/31/22 ChargePoint sees Q2 revenue 96M-$106M, consensus $105.59M 05/31/22 ChargePoint sees FY23 revenue $450M-$500M, consensus $471.57M 05/31/22 ChargePoint reports Q1 EPS (27c), consensus (19c) APPS Digital Turbine $25.45 / -1.16 (-4.36%) 05/31/22 Digital Turbine sees Q1 non-GAAP EPS 34c-35c, consensus 44c 05/31/22 Digital Turbine reports Q4 non-GAAP EPS 39c, consensus 39c 05/17/22 Digital Turbine reaffirms FY22 non-GAAP EPS $1.66-$1.68, consensus $1.67 02/08/22 Digital Turbine sees FY22 non-GAAP EPS $1.66-$1.68, consensus $1.60 AMBA Ambarella $85.23 / -2.895 (-3.29%) 05/31/22 Ambarella sees Q2 revenue $78M-$82M, consensus $91.48M 05/31/22 Ambarella reports Q1 EPS 44c, consensus 36c 03/01/22 Ambarella sees Q1 revenue $88.5M-$91.5M, consensus $90.7M 02 Jun 15 Jul SIX HPQ CRM SIX Six Flags $29.36 / -0.64 (-2.13%) 02/01/22 Cedar Fair jumps after Bloomberg report of SeaWorld takeover bid HPQ HP Inc. $38.79 / +0.06 (+0.15%) 04/23/22 Merck, CVS among dividend stocks to help whip inflation now, Barron's says 04/09/22 HP stock gets a Buffett boost, still 'a screaming buy,' Barron's says 03/30/22 TSMC says demand for consumer electronics starting to slow, Nikkei Asia reports 01/28/22 HP wins fraud case in U.K. over Autonomy acquisition, CNBC says CRM Salesforce $160.60 / -4.5 (-2.73%) 03/05/22 Cloud stocks have become a haven in tech, Barron's says VSCO SPWH SIX OSTK HPQ CRM CHPT APPS AMBA VSCO Victoria's Secret $41.27 / -1.37 (-3.21%) 01/24/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/29/21 Wall Street in Fives - Must Read Lists for Wednesday 12/29/21 Wall Street in Fives - Must Read Lists at Midday 12/29/21 Fly Intel: Pre-market Movers SPWH Sportsman's Warehouse $9.45 / -0.11 (-1.15%) 05/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/29/22 Fly Intel: After-Hours Movers 01/18/22 Fly Intel: Wall Street's top stories for Tuesday 01/18/22 Wall Street in Fives - Must Read Lists at Midday SIX Six Flags $29.36 / -0.64 (-2.13%) 05/18/22 What You Missed On Wall Street On Wednesday 05/18/22 What You Missed On Wall Street This Morning 03/04/22 What You Missed On Wall Street On Friday 03/04/22 What You Missed On Wall Street This Morning OSTK Overstock.com $31.02 / -1.295 (-4.01%) 05/27/22 Here's What You Missed in Crypto This Week 05/20/22 Here's What You Missed in Crypto This Week 05/13/22 Here's What You Missed in Crypto This Week 05/06/22 Here's What You Missed in Crypto This Week HPQ HP Inc. $38.79 / +0.06 (+0.15%) 05/23/22 What You Missed On Wall Street On Monday 05/23/22 What You Missed On Wall Street This Morning 05/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/23/22 Fly Intel: Pre-market Movers CRM Salesforce $160.60 / -4.5 (-2.73%) 05/18/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/02/22 What You Missed On Wall Street This Morning 03/01/22 Here’s what Wall Street is saying about Salesforce ahead of earnings 01/31/22 Charged: Credit Suisse says buy Tesla on post-earnings selloff CHPT ChargePoint $12.75 / -0.71 (-5.27%) 04/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/28/22 Fly Insider: GameStop, Agilent among this week's notable insider trades 03/02/22 Fly Intel: After-Hours Movers APPS Digital Turbine $25.45 / -1.16 (-4.36%) 04/26/22 What Wall Street is saying about Alphabet ahead of earnings 02/16/22 What You Missed On Wall Street On Wednesday 02/16/22 What You Missed On Wall Street This Morning 02/16/22 Google's plan to curb cross-app tracking sinking these adtech stocks AMBA Ambarella $85.23 / -2.895 (-3.29%) 03/01/22 What You Missed On Wall Street On Tuesday 03/01/22 What You Missed On Wall Street This Morning 02/28/22 Fly Intel: After-Hours Movers 02/10/22 Wall Street in Fives - Must Read Lists for Thursday 06/01/22 50th Annual Technology, Media & Telecom Conference 06/01/22 2022 Wells Fargo Energy Conference 06/13/22 Semiconductor & Software Bus Tour 06/22/22 Energy, Power, & Renewables Conference 2022 05/31/22 Ambarella - AMBA 05/31/22 ChargePoint - CHPT 05/31/22 Digital Turbine - APPS 05/31/22 Salesforce - CRM 05/31/22 HP Inc. - HPQ 05/31/22 Sportsman's Warehouse - SPWH 06/01/22 Victoria's Secret - VSCO 06/01/22 Bristow Group - VTOL 06/15/22 HP Inc. - HPQ 06/07/22 Ambarella Inc 06/09/22 Concert Pharmaceuticals, Inc. 06/09/22 Salesforce Inc 07/12/22 ChargePoint Holdings Inc VSCO SPWH OSTK LPI HPQ CRM CHPT APPS AMBA VSCO Victoria's Secret $41.27 / -1.37 (-3.21%) 05/31/22 Victoria's Secret options imply 12.5% move in share price post-earnings SPWH Sportsman's Warehouse $9.45 / -0.11 (-1.15%) 12/08/21 Sportsmans Warehouse options imply 9.7% move in share price post-earnings OSTK Overstock.com $31.02 / -1.295 (-4.01%) 04/11/22 Overstock com call volume above normal and directionally bullish 04/07/22 Overstock com put volume heavy and directionally bearish 03/01/22 Unusually active option classes on open March 1st 02/23/22 Unusually active option classes on open February 23rd LPI Laredo Petroleum $84.19 / -0.75 (-0.88%) 02/22/22 Laredo Petroleum options imply 11.2% move in share price post-earnings HPQ HP Inc. $38.79 / +0.06 (+0.15%) 05/31/22 HP Inc. options imply 7.2% move in share price post-earnings 05/27/22 Early notable gainers among liquid option names on May 27th 05/24/22 HP Inc. put volume heavy and directionally bearish 04/29/22 HP Inc. put volume heavy and directionally bearish CRM Salesforce $160.60 / -4.5 (-2.73%) 05/31/22 Salesforce options imply 7.6% move in share price post-earnings 05/31/22 Unusually active option classes on open May 31st 02/23/22 Salesforce call volume above normal and directionally bullish 01/06/22 Unusually active option classes on open January 6th CHPT ChargePoint $12.75 / -0.71 (-5.27%) 05/31/22 ChargePoint Holdings options imply 10.8% move in share price post-earnings 05/31/22 Notable open interest changes for May 31st 05/26/22 ChargePoint Holdings call volume above normal and directionally bullish 05/24/22 Notable open interest changes for May 24th APPS Digital Turbine $25.45 / -1.16 (-4.36%) 05/31/22 Digital Turbine options imply 14.6% move in share price post-earnings 05/16/22 Digital Turbine call volume above normal and directionally bullish 05/10/22 Digital Turbine call volume above normal and directionally bullish 04/25/22 Digital Turbine call volume above normal and directionally bullish AMBA Ambarella $85.23 / -2.895 (-3.29%) 05/31/22 Ambarella options imply 14.2% move in share price post-earnings
Syndicate	Conmed offers to sell $600M in convertible senior notes doe 2027 17:27 05/31/22 05/31 17:27 05/31/22 17:27 CNMD Conmed $116.37 / +0.315 (+0.27%) ShowHide Related Items >><< Company News Street Research Earnings CNMD Conmed $116.37 / +0.315 (+0.27%) 05/04/22 Conmed to acquire In2Bones Global for $145M CNMD Conmed $116.37 / +0.315 (+0.27%) 04/19/22 Piper Sandler Piper Sandler continues to recommend exposure to medtech space after J&J results 03/02/22 BofA Conmed reinstated with a Neutral at BofA 10/27/21 Piper Sandler Conmed should be bought on any weakness, says Piper Sandler 10/06/21 Fly Intel: Top five analyst upgrades CNMD Conmed $116.37 / +0.315 (+0.27%) 05/04/22 Conmed cuts FY22 adjusted EPS view to $3.50-$3.65, consensus $3.69 05/04/22 Conmed reports Q1 adjusted EPS 70c, consensus 62c 01/26/22 Conmed sees FY22 adjusted EPS $3.60-$3.85, consensus $3.74 01/26/22 Conmed reports Q4 adjusted EPS $1.07, consensus $1.06

Over a month ago
Hot Stocks	Conmed to acquire In2Bones Global for $145M » 16:49 05/04/22 05/04 16:49 05/04/22 16:49 CNMD Conmed $140.05 / +5.3 (+3.93%) CONMED "announced a… CONMED "announced a definitive agreement to acquire privately-held In2Bones Global, Inc., on a cash-free, debt-free basis, for cash consideration of $145 million at closing and up to an additional $110 million in growth-based earnout payments over a four-year period. The transaction is not subject to a financing condition. The transaction is subject to customary closing conditions, including receipt of U.S. regulatory approval, and is expected to close late in the second quarter or early in the third quarter of 2022." ShowHide Related Items >><< Street Research Earnings Events CNMD Conmed $140.05 / +5.3 (+3.93%) 04/19/22 Piper Sandler Piper Sandler continues to recommend exposure to medtech space after J&J results 03/02/22 BofA Conmed reinstated with a Neutral at BofA 10/27/21 Piper Sandler Conmed should be bought on any weakness, says Piper Sandler 10/06/21 Fly Intel: Top five analyst upgrades CNMD Conmed $140.05 / +5.3 (+3.93%) 05/04/22 Conmed cuts FY22 adjusted EPS view to $3.50-$3.65, consensus $3.69 05/04/22 Conmed reports Q1 adjusted EPS 70c, consensus 62c 01/26/22 Conmed sees FY22 adjusted EPS $3.60-$3.85, consensus $3.74 01/26/22 Conmed reports Q4 adjusted EPS $1.07, consensus $1.06 05/04/22 Conmed - CNMD 05/25/22 CONMED Corporation

Earnings	Conmed cuts FY22 adjusted EPS view to $3.50-$3.65, consensus $3.69 » 16:10 05/04/22 05/04 16:10 05/04/22 16:10 CNMD Conmed $139.54 / +4.79 (+3.55%) Previous view… Previous view $3.60-$2.85. Raises FY22 revenue view to $1.105B-$1.15B from $1.075B-$1.125B, consensus $1.09B. ShowHide Related Items >><< Street Research Earnings Events CNMD Conmed $139.54 / +4.79 (+3.55%) 04/19/22 Piper Sandler Piper Sandler continues to recommend exposure to medtech space after J&J results 03/02/22 BofA Conmed reinstated with a Neutral at BofA 10/27/21 Piper Sandler Conmed should be bought on any weakness, says Piper Sandler 10/06/21 Fly Intel: Top five analyst upgrades CNMD Conmed $139.54 / +4.79 (+3.55%) 05/04/22 Conmed reports Q1 adjusted EPS 70c, consensus 62c 01/26/22 Conmed sees FY22 adjusted EPS $3.60-$3.85, consensus $3.74 01/26/22 Conmed reports Q4 adjusted EPS $1.07, consensus $1.06 05/04/22 Conmed - CNMD 05/25/22 CONMED Corporation
Earnings	Conmed reports Q1 adjusted EPS 70c, consensus 62c » 16:09 05/04/22 05/04 16:09 05/04/22 16:09 CNMD Conmed $139.53 / +4.78 (+3.55%) Reports Q1 revenue… Reports Q1 revenue $242.3M, consensus $235.77M. "I am pleased with our start to the year as we generated momentum and finished the quarter on a strong note," commented Curt R. Hartman, CONMED's Chair of the Board, President, and Chief Executive Officer. "While we are facing larger than anticipated inflationary pressures, we remain confident in our longer-term prospects for both top and bottom-line growth." ShowHide Related Items >><< Street Research Earnings Events CNMD Conmed $139.53 / +4.78 (+3.55%) 04/19/22 Piper Sandler Piper Sandler continues to recommend exposure to medtech space after J&J results 03/02/22 BofA Conmed reinstated with a Neutral at BofA 10/27/21 Piper Sandler Conmed should be bought on any weakness, says Piper Sandler 10/06/21 Fly Intel: Top five analyst upgrades CNMD Conmed $139.53 / +4.78 (+3.55%) 01/26/22 Conmed sees FY22 adjusted EPS $3.60-$3.85, consensus $3.74 01/26/22 Conmed reports Q4 adjusted EPS $1.07, consensus $1.06 05/04/22 Conmed - CNMD 05/25/22 CONMED Corporation
Recommendations	Piper Sandler continues to recommend exposure to medtech space after J&J results » 11:33 04/19/22 04/19 11:33 04/19/22 11:33 JNJ Johnson & Johnson $184.63 / +6.99 (+3.93%) , ATRC AtriCure $59.64 / +3.94 (+7.07%) , BSX Boston Scientific $45.68 / +1.95 (+4.46%) , COO Cooper Companies $409.16 / +13.93 (+3.52%) , GMED Globus Medical $76.86 / +0.53 (+0.69%) , MDT Medtronic $111.10 / +3.055 (+2.83%) , NUVA NuVasive $59.89 / +3.56 (+6.32%) , SYK Stryker $271.35 / +12.57 (+4.86%) , ZBH Zimmer Biomet $129.15 / +4.02 (+3.21%) , ATEC Alphatec $12.66 / +0.585 (+4.84%) , SPNE SeaSpine $10.81 / +0.49 (+4.75%) , STXS Stereotaxis $3.30 / +0.005 (+0.15%) , CNMD Conmed $148.80 / +6.55 (+4.60%) , ISRG Intuitive Surgical $292.77 / +17.06 (+6.19%) , GKOS Glaukos $61.26 / +1.99 (+3.36%) , SGHT Sight Sciences $8.77 / +0.04 (+0.46%) Piper Sandler analyst… Piper Sandler analyst Matt O'Brien notes that Johnson & Johnson (JNJ) reported Q1 med device sales of $6.97B, coming in well ahead of the Street's $6.65B. Within med devices, all four business segments beat Street expectations led by Interventional which grew +17.4% and Vision which grew +13.9%, the author notes, adding that J&J did lower its revenue and EPS guidance on a full-company basis for the year though this was due to lower vaccine sales and higher currency headwinds, respectively. Notably, Johnson & Johnson did not lower its operating margin expectations as some had feared, O'Brien points out. Overall, the analyst views the results as better than expected, and continues to recommend exposure to the medtech space in 2022. Related companies in the sector include AtriCure (ATRC), Boston Scientific (BSX), Cooper Companies (COO), Globus Medical (GMED), Medtronic (MDT), NuVasive (NUVA), Stryker (SYK), Zimmer Biomet (ZBH), Alphatec (ATEC), SeaSpine (SPNE), Stereotaxis (STXS), Conmed (CNMD), Intuitive Surgical (ISRG), Glaukos (GKOS), and Sight Sciences (SGHT). ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ZBH SYK STXS SPNE SGHT NUVA MDT JNJ ISRG GMED GKOS COO BSX ZBH Zimmer Biomet $129.15 / +4.02 (+3.21%) 03/24/22 Assure Holdings appoints Kelly Shelton as VP, sales, Sherri Wagner as VP, HR 03/02/22 ZimVie to replace Tabula Rasa HealthCare in S&P 600 at open on 3/2 03/01/22 ZimVie completes separation from Zimmer Biomet SYK Stryker $271.35 / +12.57 (+4.86%) 04/11/22 Stryker says CMS grants outpatient facility code for InSpace implant 04/06/22 Spruce Point names Stryker as short target, sees 35%-75% downside risk 04/06/22 Stryker falls 5% to $254 after Spruce Point short report 03/07/22 Stryker sees Q1 EPS 'deleveraged' from operating expense standpoint STXS Stereotaxis $3.30 / +0.005 (+0.15%) 03/24/22 Poland's National Institute of Cardiology uses Stereotaxis' Genesis RMN system 03/09/22 Stereotaxis announces grand opening of new global headquarters 03/03/22 Stereotaxis anticipates revenue growth for 2022 01/27/22 Fuwai Central China installs Stereotaxis' Robotic Magnetic Navigation tech SPNE SeaSpine $10.81 / +0.49 (+4.75%) 04/11/22 SeaSpine announces commercial launch of Reef TA Interbody System 03/07/22 SeaSpine promotes Frank Vizesi to chief scientific officer 11/23/21 SeaSpine announces commercial launch of Admiral ACP System SGHT Sight Sciences $8.77 / +0.04 (+0.46%) 03/24/22 Sight Sciences announces first patient treated in TRIDENT trial 02/17/22 Sight Sciences launches 'Don't Wait for Too Late' awareness campaign 12/22/21 Sight Sciences receives FDA 510(k) clearance of TearCare System NUVA NuVasive $59.89 / +3.56 (+6.32%) 01/31/22 NuVasive names Andrew Morton as Chief Human Resources Officer 01/05/22 NuVasive receives FDA 510(k) clearance for expanded indications of Attrax Putty 12/01/21 FDA posts letter to health care providers on NuVasive device concerns MDT Medtronic $111.10 / +3.055 (+2.83%) 04/04/22 Medtronic announces long-term data from SPYRAL HTN-ON MED trial 03/24/22 Medtronic announces first patient implants in TITAN 2 OAB study 03/16/22 Medtronic's GI Genius shows 50% reduction in missed polyps during colonoscopy 03/10/22 Rockley Photonics, Medtronic to enter Bioptx development partnership JNJ Johnson & Johnson $184.63 / +6.99 (+3.93%) 04/19/22 Johnson & Johnson says continues to invest in R&D at 'competitive levels' 04/19/22 Johnson & Johnson sees 'external supply constraints' in Consumer Health unit 04/19/22 Genmab announces Q1 net sales of DARZALEX $1.86B 04/19/22 Johnson & Johnson increases quarterly dividend 6.6% to $1.13 per share ISRG Intuitive Surgical $292.77 / +17.06 (+6.19%) 02/06/22 Fly Intel: Top five weekend stock stories 01/20/22 Intuitive Surgical sees FY22 procedure growth 11%-15% 01/20/22 Intuitive says da Vinci procedures to be significantly adversely impacted in Q1 12/15/21 Intuitive Surgical receives FDA clearance for 8mm SureForm 30 Curved-Tip Stapler GMED Globus Medical $76.86 / +0.53 (+0.69%) 03/04/22 Globus Medical expands share repurchase authorization by $200M 11/15/21 NuVasive up 7% after Bloomberg says Globus Medical made takeover approach 10/19/21 Globus Medical Premieres ANTHEM mini fragment fracture system at OTA GKOS Glaukos $61.26 / +1.99 (+3.36%) 03/14/22 Glaukos commences iLink therapy clinical program 02/07/22 Glaukos names Joseph Gilliam president, COO 01/11/22 Glaukos' iDose TR shows sustained IOP reduction in Phase 2b study 01/11/22 Glaukos says first patient enrolled in presbyopia phase 2 trial COO Cooper Companies $409.16 / +13.93 (+3.52%) 02/07/22 Cooper Companies to acquire Cook Medical Reproductive Health business for $875M 02/07/22 Cooper Companies to acquire Cook Medical reproductive health business for $875M 11/18/21 Cooper Companies announces executive management changes 11/10/21 Cooper Companies to acquire Generate Life Sciences for $1.6B, sees accretion BSX Boston Scientific $45.68 / +1.95 (+4.46%) 03/16/22 Sight Sciences appoints Brenda Becker to board of directors 02/18/22 FTC approves changes to Boston Scientific divestiture agreement 12/02/21 Boston Scientific initiates trial to evaluate mCRM Modular Therapy System 11/01/21 Nevro announces update in Boston Scientific patent litigation, to pay $20M JNJ ATRC BSX COO GMED MDT NUVA SYK ZBH ATEC SPNE STXS CNMD ISRG GKOS SGHT JNJ Johnson & Johnson $184.63 / +6.99 (+3.93%) 04/19/22 BTIG J&J results will be viewed favorably for MedTech group, says BTIG 04/14/22 Raymond James Johnson & Johnson price target raised to $195 from $185 at Raymond James 04/06/22 Morgan Stanley Johnson & Johnson assumed with an Equal Weight at Morgan Stanley 03/16/22 Bernstein Bernstein downgrades J&J on 'uphill battle' for Janssen unit ATRC AtriCure $59.64 / +3.94 (+7.07%) 02/16/22 Needham AtriCure price target lowered to $79 from $92 at Needham 02/16/22 Canaccord AtriCure price target lowered to $88 from $120 at Canaccord 01/03/22 JPMorgan JPMorgan says own these medical device stocks into next week's conference 09/16/21 JPMorgan AtriCure should be bought ahead of 'exciting' 2022, says JPMorgan BSX Boston Scientific $45.68 / +1.95 (+4.46%) 04/12/22 Truist Truist starts six stocks in Medical Supplies and Devices, assumes eight others 04/12/22 Truist Boston Scientific assumed with a Buy at Truist 04/06/22 JPMorgan JPMorgan 'tentatively bullish' on medtech, sees two best positioned 03/02/22 BofA Boston Scientific added to US 1 List at BofA COO Cooper Companies $409.16 / +13.93 (+3.52%) 04/08/22 Needham Cooper Companies initiated with a Hold at Needham 03/07/22 Stephens Cooper Companies price target raised to $500 from $430 at Stephens 03/04/22 Piper Sandler Cooper Companies price target raised to $500 from $490 at Piper Sandler 01/03/22 Guggenheim Guggenheim upgrades Cooper Companies to Buy ahead of myopia franchise inflection GMED Globus Medical $76.86 / +0.53 (+0.69%) 04/12/22 Truist Globus Medical assumed with a Buy at Truist 03/28/22 Wells Fargo Globus Medical initiated with an Overweight at Wells Fargo MDT Medtronic $111.10 / +3.055 (+2.83%) 04/12/22 Truist Medtronic assumed at Hold from Buy at Truist 03/01/22 BofA Medtronic reinstated with a Buy at BofA 02/23/22 Credit Suisse Medtronic price target lowered to $135 from $142 at Credit Suisse NUVA NuVasive $59.89 / +3.56 (+6.32%) 04/12/22 Truist NuVasive assumed with a Buy at Truist 03/28/22 Wells Fargo Wells Fargo bullish on NuVasive, initiates with an Overweight SYK Stryker $271.35 / +12.57 (+4.86%) 04/18/22 BTIG Stryker price target raised to $278 from $273 at BTIG 04/12/22 Truist Stryker initiated with a Hold at Truist ZBH Zimmer Biomet $129.15 / +4.02 (+3.21%) 04/12/22 Truist Zimmer Biomet assumed at Hold from Buy at Truist 04/01/22 Citi Zimmer Biomet downgraded to Neutral from Buy at Citi ATEC Alphatec $12.66 / +0.585 (+4.84%) 03/02/22 Piper Sandler Alphatec price target lowered to $17 from $22 at Piper Sandler 12/03/21 Goldman Sachs Alphatec initiated with a Neutral at Goldman Sachs 10/28/21 Loop Capital Alphatec initiated with a Buy at Loop Capital 09/28/21 Piper Sandler Piper Sandler still bullish on Alphatec, views any weakness as good entry point SPNE SeaSpine $10.81 / +0.49 (+4.75%) 04/12/22 Truist SeaSpine assumed with a Buy at Truist 03/14/22 Piper Sandler SeaSpine price target lowered to $21 from $28 at Piper Sandler STXS Stereotaxis $3.30 / +0.005 (+0.15%) 03/03/22 Piper Sandler Piper Sandler keeps Overweight on Stereotaxis, lowers price target to $8 01/05/22 Craig-Hallum Craig-Hallum bullish on Stereotaxis, initiates with a Buy 01/05/22 Craig-Hallum Stereotaxis initiated with a Buy at Craig-Hallum 01/05/22 Loop Capital Stereotaxis initiated with a Buy at Loop Capital CNMD Conmed $148.80 / +6.55 (+4.60%) 03/02/22 BofA Conmed reinstated with a Neutral at BofA 10/27/21 Piper Sandler Conmed should be bought on any weakness, says Piper Sandler 10/06/21 Fly Intel: Top five analyst upgrades 10/06/21 Needham Conmed upgraded to Buy at Needham on double-digit revenue growth outlook ISRG Intuitive Surgical $292.77 / +17.06 (+6.19%) 04/13/22 Deutsche Bank Intuitive Surgical antitrust case heading to trial, says Deutsche Bank 04/12/22 Truist Intuitive Surgical initiated with a Buy at Truist GKOS Glaukos $61.26 / +1.99 (+3.36%) 04/18/22 BTIG Glaukos price target raised to $66 from $61 at BTIG 03/02/22 Stifel Glaukos transferred with Hold rating at Stifel 02/23/22 Citi Glaukos price target raised to $55 from $49 at Citi SGHT Sight Sciences $8.77 / +0.04 (+0.46%) 03/25/22 Citi Sight Sciences price target lowered to $35 from $39 at Citi 03/25/22 Piper Sandler Sight Sciences price target lowered to $23 from $43 at Piper Sandler 02/03/22 William Blair William Blair starts Sight Sciences at Outperform on 'massive opportunity' 02/03/22 William Blair Sight Sciences initiated with an Outperform at William Blair ZBH SYK STXS SPNE SGHT NUVA MDT JNJ ISRG GMED GKOS COO CNMD BSX ATRC ATEC ZBH Zimmer Biomet $129.15 / +4.02 (+3.21%) 02/07/22 Zimmer Biomet's ZimVie spin off sees FY22 adjusted EPS $2.10-$2.30 02/07/22 Zimmer Biomet sees FY22 adjusted EPS $6.40-$6.80, consensus $7.92 02/07/22 Zimmer Biomet reports Q4 EPS $1.95, consensus $1.98 11/05/21 Zimmer Biomet lowers FY21 EPS view to $7.32-$7.47 from $7.65-$7.95 SYK Stryker $271.35 / +12.57 (+4.86%) 03/07/22 Stryker still sees FY22 EPS $9.60-$10.00, consensus $9.79 01/27/22 Stryker sees FY22 adjusted EPS $9.60-$10.00, consensus $10.14 01/27/22 Stryker reports Q4 adjusted EPS $2.71, consensus $2.72 01/27/22 Notable companies reporting after market close STXS Stereotaxis $3.30 / +0.005 (+0.15%) 03/03/22 Stereotaxis reports Q4 EPS (5c), consensus (5c) 11/11/21 Stereotaxis sees 2021 system revenue $11M 11/11/21 Stereotaxis reports Q3 EPS (7c), consensus (5c) SPNE SeaSpine $10.81 / +0.49 (+4.75%) 03/11/22 SeaSpine sees Q1 revenue $48.5M-$49.5M, consensus $49.55M 03/11/22 SeaSpine sees 2022 revenue $226M-$230M, consensus $218.86M 03/11/22 SeaSpine reports Q4 EPS (52c), consensus (35c) 01/10/22 SeaSpine sees Q4 revenue $55.1M-$55.5M, consensus $54.46M SGHT Sight Sciences $8.77 / +0.04 (+0.46%) 03/24/22 Sight Sciences reports Q4 EPS (34c), consensus (39c) 03/24/22 Sight Sciences reports Q4 EPS (34c), consensus (39c) 01/10/22 Sight Sciences sees FY21 revenue $48.8M-$49.1M, consensus $47.93M 01/10/22 Sight Sciences reports preliminary Q4 revenue $14.5M-$14.8M, one estimate $13.7M NUVA NuVasive $59.89 / +3.56 (+6.32%) 02/23/22 NuVasive sees 2022 non-GAAP EPS $2.05-$2.35, consensus $2.31 02/23/22 NuVasive reports Q4 non-GAAP EPS 40c, consensus 48c 11/09/21 NuVasive cuts FY21 adjusted EPS view to $1.73-$1.83 from $2.25-$2.35 11/09/21 NuVasive reports Q3 adjusted EPS 32c, consensus 54c MDT Medtronic $111.10 / +3.055 (+2.83%) 02/22/22 Medtronic sees Q4 EPS $1.56-$1.58, consensus $1.58 02/22/22 Medtronic reports Q3 EPS $1.37, consensus $1.36 11/23/21 Medtronic sees Q3 EPS $1.37-$1.39, consensus $1.41 11/23/21 Medtronic backs FY22 EPS view $5.65-$5.75, consensus $5.71 JNJ Johnson & Johnson $184.63 / +6.99 (+3.93%) 04/19/22 Johnson & Johnson cuts FY22 adj. EPS view to $10.15-$10.35 from $10.40-$10.60 04/19/22 Johnson & Johnson reports Q1 adjusted EPS $2.67, consensus $2.61 04/18/22 Notable companies reporting before tomorrow's open ISRG Intuitive Surgical $292.77 / +17.06 (+6.19%) 01/20/22 Intuitive Surgical reports Q4 EPS $1.30, consensus $1.28 01/20/22 Notable companies reporting after market close 01/12/22 Intuitive Surgical sees 2021 revenue $5.71B, consensus $5.68B 01/12/22 Intuitive Surgical sees Q4 revenue $1.55B, consensus $1.51B GMED Globus Medical $76.86 / +0.53 (+0.69%) 02/17/22 Globus Medical sees FY22 EPS $2.10, consensus $2.26 02/17/22 Globus Medical reports Q4 EPS 49c, consensus 47c 11/04/21 Globus Medical backs FY21 adjusted EPS view $2.00, consensus $1.96 11/04/21 Globus Medical reports Q3 adjusted EPS 50c, consensus 45c GKOS Glaukos $61.26 / +1.99 (+3.36%) 02/22/22 Glaukos sees FY22 revenue $265M-$275M, consensus $268.2M 02/22/22 Glaukos reports Q4 EPS (31c), consensus (37c) 11/04/21 Glaukos sees FY21 net sales $285M-$290M, consensus $287.86M 11/04/21 Glaukos reports Q3 adjusted EPS (21c), consensus (24c) COO Cooper Companies $409.16 / +13.93 (+3.52%) 03/03/22 Cooper Companies backs FY22 EPS view $13.60-$14.00, consensus $14.36 03/03/22 Cooper Companies reports Q1 EPS $3.24, consensus $3.10 12/02/21 Cooper Companies sees FY22 EPS $13.60-$14.00, consensus $14.49 12/02/21 Cooper Companies reports Q4 EPS $3.28, consensus $3.37 CNMD Conmed $148.80 / +6.55 (+4.60%) 01/26/22 Conmed sees FY22 adjusted EPS $3.60-$3.85, consensus $3.74 01/26/22 Conmed reports Q4 adjusted EPS $1.07, consensus $1.06 10/27/21 Conmed narrows FY21 adjusted EPS view to $3.18-$3.23 from $3.15-$3.25 10/27/21 Conmed reports Q3 adjusted EPS 80c, consensus 75c BSX Boston Scientific $45.68 / +1.95 (+4.46%) 02/15/22 Boston Scientific sees 1c of accretion to FY22 adjusted EPS from Baylis deal 02/02/22 Boston Scientific reports Q4 adjusted EPS 45c, consensus 44c 02/01/22 Notable companies reporting before tomorrow's open ATRC AtriCure $59.64 / +3.94 (+7.07%) 02/15/22 AtriCure sees FY22 adjusted EPS ($1.12)-($1.07), consensus (94c) 02/15/22 AtriCure reports Q4 adjusted EPS (30c), consensus (29c) 01/10/22 AtriCure sees FY22 revenue $315M-$330M, consensus $321.67M 01/10/22 AtriCure reports preliminary FY21 revenue $274.3M, consensus $273.57M ATEC Alphatec $12.66 / +0.585 (+4.84%) 03/01/22 Alphatec backs FY22 revenue view of $305M, consensus $297.6M 03/01/22 Alphatec reports Q4 EPS (40c), consensus (31c) 01/10/22 Alphatec sees FY22 revenue $305M, consensus $291.86M 01/10/22 Alphatec sees Q4 revenue $73.2M-$74M, consensus $65.89M 15 Jul SYK MDT JNJ ISRG GMED BSX SYK Stryker $271.35 / +12.57 (+4.86%) 04/06/22 Spruce Point sees 35%-75% downside risk in Stryker shares 04/06/22 Spruce Point announces short position in Stryker with 'Strong Sell' rating MDT Medtronic $111.10 / +3.055 (+2.83%) 02/05/22 Medtronic stock can gain 20% as COVID subsides, Barron's says 11/06/21 Wells, Cisco among stocks powering 2021 top dividend mutual funds, Barron's says JNJ Johnson & Johnson $184.63 / +6.99 (+3.93%) 03/30/22 DOJ probes network accused of selling counterfeit HIV drugs, WSJ reports 03/27/22 Pfizer, Moderna face shareholder pressure to broaden vaccine access, WSJ says 03/23/22 Biden administration eyes new COVID booster shot recommendation, Politico says 03/19/22 Chevron, Verizon among dividend stocks to choose for retirement, Barron's says ISRG Intuitive Surgical $292.77 / +17.06 (+6.19%) 02/05/22 McDonald's, UPS among stocks to play new economic reopening, Barron's says GMED Globus Medical $76.86 / +0.53 (+0.69%) 11/15/21 Globus Medical makes takeover approach for NuVasive, Bloomberg reports 11/15/21 Globus made preliminary takeover approach to NuVasive, Bloomberg reports BSX Boston Scientific $45.68 / +1.95 (+4.46%) 01/04/22 SEC ends investigation into Boston Scientific's heart device, Reuters reports ZBH SYK SPNE SGHT MDT JNJ ISRG GMED GKOS COO BSX ZBH Zimmer Biomet $129.15 / +4.02 (+3.21%) 03/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/07/22 Wall Street in Fives - Must Read Lists for Monday 02/07/22 Wall Street in Fives - Must Read Lists at Midday 02/07/22 Fly Intel: Pre-market Movers SYK Stryker $271.35 / +12.57 (+4.86%) 04/06/22 What You Missed On Wall Street On Wednesday 04/06/22 What You Missed On Wall Street This Morning 03/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/27/22 Fly Intel: After-Hours Movers SPNE SeaSpine $10.81 / +0.49 (+4.75%) 03/11/22 What You Missed On Wall Street This Morning SGHT Sight Sciences $8.77 / +0.04 (+0.46%) 03/25/22 Fly Intel: Pre-market Movers 03/24/22 Fly Intel: After-Hours Movers MDT Medtronic $111.10 / +3.055 (+2.83%) 02/22/22 What You Missed On Wall Street On Tuesday 02/22/22 What You Missed On Wall Street This Morning 01/04/22 Fly Intel: Pre-market Movers 12/17/21 Wall Street in Fives - Must Read Lists for Friday JNJ Johnson & Johnson $184.63 / +6.99 (+3.93%) 04/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/23/22 What You Missed On Wall Street On Wednesday 03/16/22 What You Missed On Wall Street On Wednesday 03/16/22 What You Missed On Wall Street This Morning ISRG Intuitive Surgical $292.77 / +17.06 (+6.19%) 03/25/22 What You Missed On Wall Street On Friday 03/25/22 What You Missed On Wall Street This Morning 03/25/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/21/22 Wall Street in Fives - Must Read Lists for Friday GMED Globus Medical $76.86 / +0.53 (+0.69%) 03/28/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/15/21 Wall Street in Fives - Must Read Lists for Monday GKOS Glaukos $61.26 / +1.99 (+3.36%) 02/03/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/11/22 Fly Intel: After-Hours Movers 01/06/22 Fly Intel: After-Hours Movers 11/03/21 Glaukos, iRhythm soar following updated Medicare reimbursement rates COO Cooper Companies $409.16 / +13.93 (+3.52%) 12/03/21 Wall Street in Fives - Must Read Lists at Midday BSX Boston Scientific $45.68 / +1.95 (+4.46%) 02/02/22 Fly Intel: Pre-market Movers 04/19/22 Johnson & Johnson - JNJ 04/21/22 Intuitive Surgical - ISRG 04/27/22 Boston Scientific - BSX 04/28/22 Stryker - SYK 05/03/22 Zimmer Biomet - ZBH 05/03/22 AtriCure - ATRC 05/04/22 Conmed - CNMD 05/04/22 Glaukos - GKOS 05/10/22 Stereotaxis - STXS 05/10/22 Sight Sciences - SGHT 04/28/22 Johnson & Johnson 04/28/22 Intuitive Surgical Inc 05/04/22 Stryker Corp. 05/05/22 Boston Scientific Corporation 05/11/22 NuVasive, Inc. 05/13/22 Zimmer Biomet Holdings, Inc. 05/17/22 Stereotaxis 05/19/22 Boston Scientific 05/19/22 Stereotaxis, Inc. 05/25/22 AtriCure, Inc. 05/25/22 CONMED Corporation ZBH SYK MDT JNJ ISRG GKOS COO BSX ZBH Zimmer Biomet $129.15 / +4.02 (+3.21%) 03/02/22 new option listings and two option delistings on March 2nd 03/01/22 Two option delistings on March 1st SYK Stryker $271.35 / +12.57 (+4.86%) 04/19/22 Early notable gainers among liquid option names on April 19th MDT Medtronic $111.10 / +3.055 (+2.83%) 01/31/22 Medtronic put volume heavy and directionally bearish 12/16/21 Medtronic put volume heavy and directionally bearish 11/15/21 Medtronic put volume heavy and directionally bearish JNJ Johnson & Johnson $184.63 / +6.99 (+3.93%) 04/19/22 Unusually active option classes on open April 19th 01/25/22 Unusually active option classes on open January 25th 12/17/21 Unusually active option classes on open December 17th 11/12/21 Unusually active option classes on open November 12th ISRG Intuitive Surgical $292.77 / +17.06 (+6.19%) 01/20/22 Intuitive Surgical options imply 3.6% move in share price post-earnings 01/10/22 Intuitive Surgical call volume above normal and directionally bullish 10/19/21 Intuitive Surgical options imply 7.3% move in share price post-earnings GKOS Glaukos $61.26 / +1.99 (+3.36%) 11/04/21 Glaukos options imply 14.1% move in share price post-earnings COO Cooper Companies $409.16 / +13.93 (+3.52%) 12/02/21 Cooper Companies options imply 4.2% move in share price post-earnings BSX Boston Scientific $45.68 / +1.95 (+4.46%) 04/14/22 Boston Scientific call volume above normal and directionally bullish 03/18/22 Boston Scientific call volume above normal and directionally bullish 02/23/22 Boston Scientific call volume above normal and directionally bullish 02/18/22 Boston Scientific call volume above normal and directionally bullish

Over a quarter ago
Initiation	Conmed reinstated with a Neutral at BofA » 05:09 03/02/22 03/02 05:09 03/02/22 05:09 CNMD Conmed $144.45 / -1.755 (-1.20%) BofA analyst Travis Steed… BofA analyst Travis Steed reinstated coverage of Conmed with a Neutral rating and $155 price target. The analyst is more confident in the company's margin outlook but says the stock looks fairly valued at these levels relative to other opportunities in medtech. ShowHide Related Items >><< Street Research Earnings CNMD Conmed $144.45 / -1.755 (-1.20%) 10/27/21 Piper Sandler Conmed should be bought on any weakness, says Piper Sandler 10/06/21 Fly Intel: Top five analyst upgrades 10/06/21 Needham Conmed upgraded to Buy at Needham on double-digit revenue growth outlook 10/06/21 Needham Conmed upgraded to Buy from Hold at Needham CNMD Conmed $144.45 / -1.755 (-1.20%) 01/26/22 Conmed sees FY22 adjusted EPS $3.60-$3.85, consensus $3.74 01/26/22 Conmed reports Q4 adjusted EPS $1.07, consensus $1.06 10/27/21 Conmed narrows FY21 adjusted EPS view to $3.18-$3.23 from $3.15-$3.25 10/27/21 Conmed reports Q3 adjusted EPS 80c, consensus 75c
Earnings	Conmed sees FY22 adjusted EPS $3.60-$3.85, consensus $3.74 » 16:10 01/26/22 01/26 16:10 01/26/22 16:10 CNMD Conmed $121.61 / -2.22 (-1.79%) Sees FY22 revenue… Sees FY22 revenue $1.075B-$1.125B, consensus $1.11B. ShowHide Related Items >><< Street Research Earnings On The Fly Events CNMD Conmed $121.61 / -2.22 (-1.79%) 10/27/21 Piper Sandler Conmed should be bought on any weakness, says Piper Sandler 10/06/21 Fly Intel: Top five analyst upgrades 10/06/21 Needham Conmed upgraded to Buy at Needham on double-digit revenue growth outlook 10/06/21 Needham Conmed upgraded to Buy from Hold at Needham CNMD Conmed $121.61 / -2.22 (-1.79%) 01/26/22 Conmed reports Q4 adjusted EPS $1.07, consensus $1.06 10/27/21 Conmed narrows FY21 adjusted EPS view to $3.18-$3.23 from $3.15-$3.25 10/27/21 Conmed reports Q3 adjusted EPS 80c, consensus 75c 07/28/21 Conmed raises FY21 EPS view to $3.15-$3.25 from $3.05-$3.20 CNMD Conmed $121.61 / -2.22 (-1.79%) 07/28/21 Fly Intel: After-Hours Movers 01/26/22 Conmed - CNMD 01/26/22 Conmed - CNMD

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial